Comparative Analysis of Cell-Free miR-205-5p, let-7f-5p, and miR-483-5p Expression in Ovarian Cell Cultures and Plasma Samples of Patients with Ovarian Cancer
Source abstract
Abstract
The term liquid biopsy reveals a non-invasive diagnostic method that might be based on the quantification of cell-free microRNAs in body fluids. However, the identification of candidates for liquid biopsy is challenging. Our aim was to compare the cell-free expression of miR-483-5p, miR-205-5p, and let-7f-5p in ovarian cell cultures and plasma samples of patients with ovarian cancer. Both the intracellular and cell-free expression of miR-205-5p and let-7f-5p proved to be higher in the Estrogen Receptor α (ERα) expressing PEO1 cell-line than in the estrogen non-sensitive A2780. Moreover, the expression of let-7f-5p was up-regulated in response to estradiol exposure that was diminished after the addition of an ERα selective antagonist. MiR-483-5p had lower intracellular and cell-free expression in PEO1. All these miRNAs had detectable expression level in plasma samples, among which miR-205-5p proved to be overexpressed in the plasma samples of patients with ovarian tumors compared to healthy controls and possessed an acceptable diagnostic potential with ROC-AUC 0.683 (95% CI 0.57–0.795). Functional annotation clustering of the target genes of miR-205-5p revealed several clusters involved in cancer development. We suggest that miR-205-5p might be a promising biomarker candidate in ovarian cancer that should be further analyzed in larger sample size.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: MicroRNA in disease regulation · Cancer-related molecular mechanisms research · Circular RNAs in diseases
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Human Genetics, Faculty of Medicine, University of Debrecen, H-4032 Debrecen, Hungary
Faculty of Pharmacy, University of Debrecen, H-4032 Debrecen, Hungary
Department of Obstetrics and Gynecology, Faculty of Medicine, University of Debrecen, H-4032 Debrecen, Hungary
Funding
New National Excellence Program of the Ministry for Innovation and Technology from the source of the National Research, Development and Innovation Fund
References (47)
Show source-provided references
1. Szilágyi, M., Pös, O., Márton, É., Buglyó, G., Soltész, B., Keserű, J., Penyige, A., Szemes, T., and Nagy, B. (2020). Circulating Cell-Free Nucleic Acids: Main Characteristics and Clinical Application. Int. J. Mol. Sci., 21.10.3390/ijms21186827 ↗
2. Larrea, E., Sole, C., Manterola, L., Goicoechea, I., Armesto, M., Arestin, M., Caffarel, M.M., Araujo, A.M., Araiz, M., and Fernandez-Mercado, M. (2016). New Concepts in Cancer Biomarkers: Circulating miRNAs in Liquid Biopsies. Int. J. Mol. Sci., 17.10.3390/ijms17050627 ↗
3. MicroRNAs in cancer: Biomarkers, functions and therapy10.1016/j.molmed.2014.06.005 ↗
4. Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation10.3389/fendo.2018.00402 ↗
5. Cancer statistics, 201810.3322/caac.21442 ↗
6. Epidemiology of ovarian cancer: A review10.20892/j.issn.2095-3941.2016.0084 ↗
7. Circulating biomarkers in epithelial ovarian cancer diagnosis: From present to future perspective10.21037/atm.2017.05.13 ↗
8. Clinical use of cancer biomarkers in epithelial ovarian cancer: Updated guidelines from the European Group on Tumor Markers10.1097/IGC.0000000000000586 ↗
9. Circulating epithelial-mesenchymal transition-associated miRNAs are promising biomarkers in ovarian cancer10.1016/j.jbiotec.2019.04.003 ↗
10. Penyige, A., Márton, É., Soltész, B., Szilágyi-Bónizs, M., Póka, R., Lukács, J., Széles, L., and Nagy, B. (2019). Circulating miRNA profiling in plasma samples of ovarian cancer patients. Int. J. Mol. Sci., 20.10.3390/ijms20184533 ↗
11. Márton, É., Varga, A., Széles, L., Göczi, L., Penyige, A., Nagy, B., and Szilágyi, M. (2020). The Cell-Free Expression of MiR200 Family members correlates with estrogen sensitivity in human epithelial ovarian cells. Int. J. Mol. Sci., 21.10.3390/ijms21249725 ↗
12. (2021, January 20). miRTargetLink. Available online: https://ccb-web.cs.uni-saarland.de/mirtargetlink/multinet.php.
13. Bioinformatics enrichment tools: Paths toward the comprehensive functional analysis of large gene lists10.1093/nar/gkn923 ↗
14. Antagonists selective for estrogen receptor α10.1210/endo.143.3.8704 ↗
15. MiR-205 in cancer: An angel or a devil?10.1016/j.ejcb.2012.11.002 ↗
16. Chauhan, N., Dhasmana, A., Jaggi, M., Chauhan, S.C., and Yallapu, M.M. (2020). miR-205: A Potential biomedicine for cancer therapy. Cells, 9.10.3390/cells9091957 ↗
17. miR-200a/miR-141 and miR-205 upregulation might be associated with hormone receptor status and prognosis in endometrial carcinomas
18. Suppression of cell growth and invasion by miR-205 in breast cancer10.1038/cr.2009.18 ↗
19. MiR-130a, miR-203 and miR-205 jointly repress key oncogenic pathways and are downregulated in prostate carcinoma10.1038/onc.2012.55 ↗
20. Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma10.1200/JCO.2008.19.4134 ↗
21. Micro-RNA profiling in kidney and bladder cancers
22. Eyking, A., Reis, H., Frank, M., Gerken, G., Schmid, K.W., and Cario, E. (2016). MiR-205 and MiR-373 are associated with aggressive human mucinous colorectal cancer. PLoS ONE, 11.10.1371/journal.pone.0156871 ↗
23. Effect of miR‑205 on proliferation and migration of thyroid cancer cells by targeting CCNB2 and the mechanism
24. MicroRNA Signatures in Human Ovarian Cancer10.1158/0008-5472.CAN-07-1936 ↗
25. MicroRNA-205 promotes cell invasion by repressing TCF21 in human ovarian cancer10.1186/s13048-017-0328-1 ↗
26. Upregulation of MiR-205 transcriptionally suppresses SMAD4 and PTEN and contributes to human ovarian cancer progression10.1038/srep41330 ↗
27. miR-205 regulates the proliferation and invasion of ovarian cancer cells via suppressing PTEN/SMAD4 expression
28. Ovarian cancer cell-secreted exosomal miR-205 promotes metastasis by inducing angiogenesis10.7150/thno.37455 ↗
29. Zheng, H., Zhang, L., Zhao, Y., Yang, D., Song, F., Wen, Y., Hao, Q., Hu, Z., Zhang, W., and Chen, K. (2013). Plasma miRNAs as diagnostic and prognostic biomarkers for ovarian cancer. PLoS ONE, 8.10.1371/journal.pone.0077853 ↗
30. miR-205 promotes tumor proliferation and invasion through targeting ESRRG in endometrial carcinoma10.3892/or.2013.2400 ↗
31. The silent healer: miR-205-5p up-regulation inhibits epithelial to mesenchymal transition in colon cancer cells by indirectly up-regulating E-cadherin expression10.1038/s41419-017-0102-8 ↗
32. The role of let-7 in cell differentiation and cancer10.1677/ERC-09-0184 ↗
33. Vesicle-related microRNAs in plasma of nonsmall cell lung cancer patients and correlation with survival10.1183/09031936.00029610 ↗
34. Expression of serum miR-16, let-7f, and miR-21 in patients with hepatocellular carcinoma and their clinical significances10.7754/Clin.Lab.2013.130133 ↗
35. Liang, S., He, L., Zhao, X., Miao, Y., Gu, Y., Guo, C., Xue, Z., Dou, W., Hu, F., and Wu, K. (2011). MicroRNA Let-7f Inhibits tumor invasion and metastasis by targeting MYH9 in human gastric cancer. PLoS ONE, 6.10.1371/journal.pone.0018409 ↗
36. Let-7as biomarker, prognostic indicator, and therapy for precision medicine in cancer10.1186/s40169-019-0240-y ↗
37. Estradiol-regulated microRNAs control estradiol response in breast cancer cells10.1093/nar/gkp500 ↗
38. Estrogen Receptor, Inflammatory, and FOXO Transcription Factors Regulate Expression of Myasthenia Gravis-Associated Circulating microRNAs10.3389/fimmu.2020.00151 ↗
39. miR–483-5p promotes prostate cancer cell proliferation and invasion by targeting RBM510.1590/s1677-5538.ibju.2016.0595 ↗
40. Identification of cell-free microRNAs in the urine of patients with prostate cancer10.1016/j.urolonc.2014.09.015 ↗
41. Upregulated miR-483-5p expression as a prognostic biomarker for esophageal squamous cell carcinoma10.3233/CBM-160506 ↗
42. Serum miR-483-5p and miR-195 are predictive of recurrence risk in adrenocortical cancer patients10.1530/ERC-13-0051 ↗
43. Serum miR-483-5p: A novel diagnostic and prognostic biomarker for patients with oral squamous cell carcinoma10.1007/s13277-015-3514-z ↗
44. Exploration of Genome-Wide Circulating MicroRNA in Hepatocellular Carcinoma: MiR-483-5p as a Potential Biomarker10.1158/1055-9965.EPI-13-0237 ↗
45. MiR-34a and miR-483-5p are candidate serum biomarkers for adrenocortical tumors10.1016/j.surg.2013.06.022 ↗
46. MiRNA expression signature for potentially predicting the prognosis of ovarian serous carcinoma10.1007/s13277-013-0928-3 ↗
47. miR-483–5p and miR-486–5p are down-regulated in cumulus cells of metaphase II oocytes from women with polycystic ovary syndrome10.1016/j.rbmo.2015.06.023 ↗